Literature DB >> 23358741

Assessment of XAF1 as A Biomarker to Differentiate Hepatocellular Carcinoma from Nonneoplastic Liver Tissues.

Ying Lin1, Wei Li.   

Abstract

OBJECTIVE: XIAP-associated factor 1 (XAF1) expression has been shown to be related with apoptosis in hepatocellular carcinoma (HCC). However, the correlation of XAF1 expression with HCC tumor grade has not been intensively assessed. XIAP-associated factor-1 (XAF1) is an important apoptosis inducer in human HCC. The aim of this study is to determine the correlation between XAF1 expression and HCC histopathological grades.
METHODS: The mRNA levels of XAF1 in 24 paired HCC-nonneoplastic specimens were quantified by real-time reverse transcription PCR (RT-PCR). Protein levels of XAF1 in 110 paired HCC-noncancer tissues were investigated by immunostaining specimens on a tissue microarray (TMA). Correlations between XAF1 mRNA levels or protein expression and clinicopathological features were assessed by statistical analysis.
RESULTS: Both XAF1 mRNA and protein were significantly under-expressed in HCC tissues compared to their non-neoplastic counterparts. No significant relationship was found between XAF1 mRNA or protein expression and histological tumor grade.
CONCLUSION: All these data suggest that XAF1 is a potential biomarker for differentiating HCC with noncancerous tissues.

Entities:  

Keywords:  Biomarker; HCC; Tissue microarray; Tumor grade; XAF1

Year:  2012        PMID: 23358741      PMCID: PMC3555281          DOI: 10.1007/s11670-012-0201-0

Source DB:  PubMed          Journal:  Chin J Cancer Res        ISSN: 1000-9604            Impact factor:   5.087


  39 in total

Review 1.  XIAP, the guardian angel.

Authors:  M Holcik; R G Korneluk
Journal:  Nat Rev Mol Cell Biol       Date:  2001-07       Impact factor: 94.444

Review 2.  The IAP proteins: caspase inhibitors and beyond.

Authors:  B W Richter; C S Duckett
Journal:  Sci STKE       Date:  2000-08-08

Review 3.  IAP proteins: blocking the road to death's door.

Authors:  Guy S Salvesen; Colin S Duckett
Journal:  Nat Rev Mol Cell Biol       Date:  2002-06       Impact factor: 94.444

4.  The IAP proteins.

Authors:  Martin Holcik
Journal:  Trends Genet       Date:  2002-10       Impact factor: 11.639

Review 5.  XIAP: apoptotic brake and promising therapeutic target.

Authors:  M Holcik; H Gibson; R G Korneluk
Journal:  Apoptosis       Date:  2001-08       Impact factor: 4.677

6.  Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition.

Authors:  C Du; M Fang; Y Li; L Li; X Wang
Journal:  Cell       Date:  2000-07-07       Impact factor: 41.582

7.  Translational upregulation of X-linked inhibitor of apoptosis (XIAP) increases resistance to radiation induced cell death.

Authors:  M Holcik; C Yeh; R G Korneluk; T Chow
Journal:  Oncogene       Date:  2000-08-24       Impact factor: 9.867

8.  Expression and genetic analysis of XIAP-associated factor 1 (XAF1) in cancer cell lines.

Authors:  W G Fong; P Liston; E Rajcan-Separovic; M St Jean; C Craig; R G Korneluk
Journal:  Genomics       Date:  2000-11-15       Impact factor: 5.736

9.  Characterization of E2F3a function in HepG2 liver cancer cells.

Authors:  Wei Li; Guo-Xin Ni; Ping Zhang; Zheng-Xi Zhang; Wei Li; Qiang Wu
Journal:  J Cell Biochem       Date:  2010-12-01       Impact factor: 4.429

10.  Identification of XAF1 as an antagonist of XIAP anti-Caspase activity.

Authors:  P Liston; W G Fong; N L Kelly; S Toji; T Miyazaki; D Conte; K Tamai; C G Craig; M W McBurney; R G Korneluk
Journal:  Nat Cell Biol       Date:  2001-02       Impact factor: 28.824

View more
  2 in total

1.  p53 mediated apoptosis in osteosarcoma MG-63 cells by inhibition of FANCD2 gene expression.

Authors:  Peng Xia; Yifu Sun; Changjun Zheng; Tingting Hou; Mingyang Kang; Xiaoyu Yang
Journal:  Int J Clin Exp Med       Date:  2015-07-15

2.  Impact of X-linked inhibitor of apoptosis protein on survival of nasopharyngeal carcinoma patients following radiotherapy.

Authors:  Minzhu Ren; Zhenhua Wang; Guowei Gao; Xiaohua Gu; Liping Wu; Lijun Chen
Journal:  Tumour Biol       Date:  2016-04-05
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.